Your new post is loading...
Peregrine has announced promising clinical data from a Phase I trial evaluating bavituximab therapy in patients with metastatic breast cancer.
Via Krishan Maggon
|
Rescooped by Gilbert C FAURE from Top Selling Monoclonal Antibodies |
Scoop.it!
Via Krishan Maggon
Article first published online: 31 MAR 2015
DOI: 10.1002/cam4.447
© 2015 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Issue
Cancer MedicineEarly View (Online Version of Record published before inclusion in an issue)
A phase I clinical trial of bavituximab and paclitaxel in patients with HER2 negative metastatic breast cancerPavani Chalasani1,*, Marilyn Marron1,Denise Roe1, Kathryn Clarke1, Maria Iannone1, Robert B. Livingston1, Joseph S. Shan2 andAlison T. Stopeck3
Article first published online: 31 MAR 2015
DOI: 10.1002/cam4.447
© 2015 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Issue
Cancer Medicine
Early View (Online Version of Record published before inclusion in an issue)